Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Norwich Ventures is a specialized venture capital firm founded in 2004 and headquartered in Waltham, Massachusetts. The firm focuses on early-stage investments in the medtech sector, supporting entrepreneurs who are developing technologies aimed at addressing significant unmet medical needs. Norwich Ventures has established a reputation for its commitment to investing in companies that demonstrate a clear path to proof of concept and possess capital-efficient business models.
As of now, Norwich Ventures manages a fund size of $90 million, known as the Medtech Convergence Fund (MCF). The firm has a regional office in Wyomissing, Pennsylvania, and emphasizes a long-term investment perspective. Notable milestones include successful exits from companies such as Intelligent Bio-systems and Rhythmia Medical, which were acquired by Qiagen and Boston Scientific, respectively. The firm continues to expand its portfolio, focusing on innovative solutions in healthcare.
Norwich Ventures invests primarily in early-stage medtech companies across various fields of medicine, including electrophysiology, genomics, and women's health. The firm provides initial capital in seed and pre-seed rounds, emphasizing a long-term investment perspective. Their investment strategy is centered around identifying best-in-class medtech companies that demonstrate capital-efficient approaches, clear barriers to entry, and a quick path to proof of concept.
The firm actively seeks out entrepreneurs who are addressing large unmet medical needs, ensuring that their investments align with significant healthcare challenges. Norwich Ventures values companies that can demonstrate innovative technologies and a strong potential for growth within the medtech landscape. Their focus on healthcare allows them to leverage their expertise and connections to support portfolio companies effectively.
Norwich Ventures has a diverse portfolio of companies within the medtech sector. Notable past investments include:
Current portfolio companies include:
These companies reflect Norwich Ventures' commitment to investing in technologies that address critical healthcare needs and demonstrate significant growth potential.
Aaron Sandoski: Co-Founder and Managing Director. He joined Norwich Ventures in 2020 as a founding partner and is also affiliated with SV Health Investors. Sandoski serves on the board of Podimetrics and has extensive experience in the medtech sector.
Marlin Miller: Co-Founder and Senior Advisor. Miller brings a wealth of experience in venture capital and has been instrumental in guiding the firm's investment strategy.
Jamie Watkins: Advisor. Watkins provides strategic insights and industry connections to support the firm's portfolio companies.
Phil Fleck: Co-Founder (In Memoriam). Fleck was a key figure in establishing Norwich Ventures and contributed significantly to its early success.
Submit your pitch through their website contact form.
In April 2023, Norwich Ventures announced the closing of its $90 million Medtech Convergence Fund, aimed at investing in early-stage medtech companies. This fund will enable the firm to expand its portfolio and support innovative technologies in the healthcare sector.
In March 2023, Norwich Ventures celebrated the acquisition of Intelligent Bio-systems by Qiagen, marking a significant exit for the firm. This acquisition underscores the firm's successful investment strategy and its focus on companies with strong growth potential.
What are Norwich Ventures' investment criteria?
Norwich Ventures focuses on early-stage medtech companies that address significant unmet medical needs. They look for capital-efficient business models, clear barriers to entry, and a quick path to proof of concept.
How can I apply or pitch to Norwich Ventures?
Founders can reach out directly through their website or contact them via phone. A well-prepared pitch deck that outlines the technology, market opportunity, and team is essential.
What makes Norwich Ventures different from other VC firms?
Norwich Ventures specializes in the medtech sector, providing not only capital but also strategic guidance and industry connections to help portfolio companies navigate the complexities of the healthcare landscape.
What is the geographic scope of Norwich Ventures' investments?
The firm primarily invests in early-stage companies located in the United States, focusing on the healthcare sector.
What is the typical check size for investments?
While specific check sizes are not disclosed, Norwich Ventures typically invests in seed and pre-seed rounds, which generally range from several hundred thousand to a few million dollars.
What kind of post-investment involvement does Norwich Ventures have?
Norwich Ventures provides ongoing support to portfolio companies, including strategic guidance, mentorship, and access to their network within the medtech industry.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.